These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
699 related items for PubMed ID: 15019059
21. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918 [Abstract] [Full Text] [Related]
22. Prevalence of specific IgA and IgM anti-HBc antibodies compared with HBV DNA in the sera of HBsAg chronic carriers. Elsana S, Shemer-Avni Y, Sikuler E, Sarov B, Naggan L, Bar-Shany S, Gilon E, Yaari A, Orgel M, Frazer GM, Margalith M. J Hum Virol; 1997 Jan; 1(1):52-7. PubMed ID: 10195231 [Abstract] [Full Text] [Related]
23. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM. J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185 [Abstract] [Full Text] [Related]
24. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, Mazzucco W, Virdone R, Palazzo U, Villafrate MR, Tagger A, Romano N. J Med Virol; 2008 Apr; 80(4):577-82. PubMed ID: 18297707 [Abstract] [Full Text] [Related]
25. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics. Dati F, Denoyel G, van Helden J. J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761 [Abstract] [Full Text] [Related]